Health2 weeks ago
Eli Lilly Achieves Breakthrough Results in Ulcerative Colitis Drug Trial
Eli Lilly (NYSE: LLY) has reported promising results from a late-stage trial of its drug, Omvoh (mirikizumab-mrkz), aimed at treating patients with moderately to severely active...
